Glycomet Tablet 5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
MFDS item code 202201744 · Approved 2022.04.29
Improves glycemic control in adults with type 2 diabetes mellitus
This medication helps control blood sugar levels in adults with type 2 diabetes through the combined administration of empagliflozin and metformin. It should be used in conjunction with dietary and exercise therapy to enhance blood sugar management, especially suitable for adult patients whose blood sugar is not adequately controlled. Additionally, patients with confirmed cardiovascular disease require caution regarding the occurrence of cardiovascular events, necessitating reference to clinical trial information from specialists. Overall, this medication effectively improves blood sugar control in patients with type 2 diabetes.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose is missed, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is required in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Careful Administration, subsection 1)). If renal function declines to a CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, subsection 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into account.
This medication aids in controlling blood sugar. However, there is a risk of rare but serious side effects such as lactic acidosis, which can be dangerous and potentially life-threatening due to excessive lactate accumulation in the body. When taking this medication alongside insulin or other diabetes medications, it is important to closely monitor blood sugar levels, as hypoglycemia may occur. Patients with poor kidney function, severe infections, dehydration, or heart problems should not take this medication. Additionally, this medication should be temporarily discontinued before and after examinations using iodinated contrast agents, restarting only after kidney function has been confirmed as normal. It is also safest for pregnant or breastfeeding women not to take this medication. During treatment, increased urination or urinary and genital infections may occur; if symptoms appear, consult a healthcare provider. Regular checks may also be needed due to the risk of vitamin B12 deficiency. Alcohol consumption may increase the risk of side effects, so it is advisable to avoid it. Elderly patients and those with impaired kidney function should take this medication with particular caution, receiving regular kidney function checks. In cases of surgical procedures or severe acute illness, discontinuation of this medication may also be necessary. Throughout the treatment, attention should be paid to symptoms of hypoglycemia, especially in cases of irregular meals or excessive exercise. If unusual symptoms or side effects are suspected, it is important to consult a physician or pharmacist immediately.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent exposure to air and moisture, and keep it at room temperature between 1°C and 30°C. This helps maintain the medication's effectiveness for a longer time.
White, biconvex oval film-coated tablets with a yellow tint
60 tablets/bottle, 60 tablets/box [(10 tablets/PTP×6)], 10 tablets/box [(10 tablets/PTP×1)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.